Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial

EuroIntervention

Volumn 10, Issue 11, 2015, Pages 1276-1279

  Löwik, Marije M ^a   Lam, Ming Kai ^a   Sen, Hanim ^a   Tandjung, Kenneth ^a   Houwelingen, K Gert ^a   De Man, Frits H A F ^a   Stoel, Martin G ^a   Louwerenburg, J W ^a   Linssen, Gerard C M ^b   Doggen, Carine J M ^c   Von Birgelen, Clemens ^a,c  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b TWENTEBORG HOSPITAL   (Netherlands)

^c UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Co Cr EES; Co Cr R ZES; Coronary revascularisation; Everolimus eluting stent(s); Long term outcome; Long term result(s); Percutaneous coronary intervention(s); Randomised study; Second generation drug eluting stent(s); Stent thrombosis; Stent(s); TWENTE trial; Zotarolimus eluting stent(s)

Indexed keywords

ACETYLSALICYLIC ACID; PURINERGIC P2Y RECEPTOR ANTAGONIST; ANTINEOPLASTIC AGENT; EVEROLIMUS; RAPAMYCIN; ZOTAROLIMUS;

ANTICOAGULANT THERAPY; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DEVICE SAFETY; DRUG ELUTING STENT; EVEROLIMUS ELUTING STENT; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS; STENT THROMBOSIS; TREATMENT OUTCOME; ZOTAROLIMUS ELUTING STENT; ACUTE CORONARY SYNDROME; AGED; ANALOGS AND DERIVATIVES; ANGINA, STABLE; CARDIOVASCULAR DISEASE; CORONARY STENOSIS; DEVICES; FEMALE; HEART MUSCLE REVASCULARIZATION; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; REOPERATION; THROMBOSIS; UTILIZATION;

ACUTE CORONARY SYNDROME; AGED; ANGINA, STABLE; ANTINEOPLASTIC AGENTS; CARDIOVASCULAR DISEASES; CORONARY STENOSIS; DRUG-ELUTING STENTS; EVEROLIMUS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PERCUTANEOUS CORONARY INTERVENTION; REOPERATION; SIROLIMUS; THROMBOSIS; TREATMENT OUTCOME;

EID: 84927620618     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJY14M08_11     Document Type: Article

References (6)

1. Taniwaki M, Stefanini GG, Silber S, Richardt G, Vranckx P, Serruys PW, Buszman PE, Kelbaek H, Windecker S. Four year clinical outcomes and predictors of repeat revascularization in patients treated with new generation drug-eluting stents in the RESOLUTE All Comers Randomized Trial. J Am Coll Cardiol. 2014;63:1617-25.
2. Von Birgelen C, Basalus MW, Tandjung K, van Houwelingen KG, Stoel MG, Louwerenburg JH, Linssen GC, Saïd SA, Kleijne MA, Sen H, Löwik MM, van der Palen J, Verhorst PM, de Man FH. A randomized controlled trial in second-generation zotarolimuseluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial. J Am Coll Cardiol. 2012;59:1350-61.
3. Tandjung K, Sen H, Lam MK, Basalus MW, Louwerenburg JH, Stoel MG, van Houwelingen KG, de Man FH, Linssen GC, Saïd SA, Nienhuis MB, Löwik MM, Verhorst PM, van der Palen J, von Birgelen C. Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trial. J Am Coll Cardiol. 2013;61:2406-16.
4. Sen H, Tandjung K, Basalus MW, Löwik MM, van Houwelingen GK, Stoel MG, Louwerenburg HW, de Man FH, Linssen GC, Nijhuis R, Nienhuis MB, Verhorst PM, van der Palen J, von Birgelen C. Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and Xience V drug-eluting stents. EuroIntervention. 2012;8:664-71.
5. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-51.
6. Vranckx P, Cutlip DE, Mehran R, Kint PP, Silber S, Windecker S, Serruys PW. Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies. EuroIntervention. 2010;5:871-4.